Shareholding disclosure

Pierpaolo Cerani

Declared position

16.4%

Threshold

Crossed upwards

Timeline

Published

17.02.2021

Transaction

09.02.2021

Voting rights breakdown

Voting rights acquired16.4%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL2G00044

Beneficial owner

Pierpaolo Cerani

Declared address

Pierpaolo Cerani, Estoril

Reference is made to the disclosure dated 15 February 2021 regarding the termination of a group with Cristina Canepa and Giovanni Cusmano

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Pierpaolo Cerani

IGEA Pharma N.V.17.02.2021TAL2G00044

Disclosure summary

Pierpaolo Cerani disclosed a holding in IGEA Pharma N.V. on the acquisition side, published by SIX Exchange Regulation on 17.02.2021, at 16.4% of voting rights. Notice category: Single shareholder.

Disclosed position

16.4%

Voting rights acquired

Voting rights acquired16.4%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Pierpaolo Cerani disclosed a holding in IGEA Pharma N.V., published on 17.02.2021.

Publication date17.02.2021

Transaction date09.02.2021

Issuing companyIGEA Pharma N.V.

Beneficial ownerPierpaolo Cerani

Declared addressPierpaolo Cerani, Estoril

CategorySingle shareholder

Voting rights acquired16.4%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAL2G00044

Conditions

Reference is made to the disclosure dated 15 February 2021 regarding the termination of a group with Cristina Canepa and Giovanni Cusmano

Source: SIX Exchange Regulation · Publication date: 17.02.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open